
President Trump’s tweeting still has the ability to rattle biopharma stocks, as a cryptic missive early Tuesday sent company shares south.
“I am working on a new system where there will be competition in the Drug Industry,” he wrote on Twitter. “Pricing for the American people will come way down!”